Search | New Scientist

Why it's good that NHS England is cutting back on prescriptions

1 December 2017

Patients in England are set to lose access to a raft of prescription drugs through the National Health Service – but only overpriced, ineffective or dangerous ones

DNA testing firms are cashing in our genes. Should we get a cut?

4 October 2017

Companies like 23andMe that offer to reveal your genetic secrets from a spit test can also sell your data to drug developers for big sums

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Subject

Section

Type

Topics

Author

Issue

Premium

Why it's good that NHS England is cutting back on prescriptions

DNA testing firms are cashing in our genes. Should we get a cut?

Sign up to our weekly newsletter